Literature DB >> 12777194

A trial of adjuvant therapy in colorectal cancer: the VICTOR trial.

Stuart Pendlebury1, Francesca Duchesne, Katharine A Reed, Justine L Smith, David J Kerr.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12777194     DOI： 10.3816/CCC.2003.n.013

Source DB:  PubMed          Journal:  Clin Colorectal Cancer        ISSN： 1533-0028            Impact factor:   4.481


× No keyword cloud information.
  6 in total

1.  Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer.

Authors:  Robert N Jorissen; Peter Gibbs; Michael Christie; Saurabh Prakash; Lara Lipton; Jayesh Desai; David Kerr; Lauri A Aaltonen; Diego Arango; Mogens Kruhøffer; Torben F Orntoft; Claus Lindbjerg Andersen; Mike Gruidl; Vidya P Kamath; Steven Eschrich; Timothy J Yeatman; Oliver M Sieber
Journal:  Clin Cancer Res       Date:  2009-12-15       Impact factor: 12.531

2.  Chemopreventive effect of nonsteroidal anti-inflammatory drugs on the development of a new colorectal polyp or adenoma in a high-risk population: a meta-analysis.

Authors:  Emine Arzu Kanik; Hakan Canbaz; Tahsin Colak; Suha Aydin
Journal:  Curr Ther Res Clin Exp       Date:  2004-07

Review 3.  Relative cardiovascular and gastrointestinal safety of non-selective non-steroidal anti-inflammatory drugs versus cyclo-oxygenase-2 inhibitors: implications for clinical practice.

Authors:  José Pedro Henriques Patrício; Jorge Pinto Pereira Barbosa; Rui Miguel Monteiro Ramos; Nuno Filipe Pimenta Antunes; Pedro Carlos Santos de Melo
Journal:  Clin Drug Investig       Date:  2013-03       Impact factor: 2.859

4.  Survival benefit of primary and metastatic tumor resection for colon cancer with liver metastases: A population based, propensity score-matched study.

Authors:  Yunfeng Qiao; Yunfeng Qiao; Huijun Li; Jinge Fu; Shuping You
Journal:  Front Surg       Date:  2022-08-30

Review 5.  Adjuvant therapy for completely resected stage II colon cancer.

Authors:  Alvaro Figueredo; Megan E Coombes; Som Mukherjee
Journal:  Cochrane Database Syst Rev       Date:  2008-07-16

6.  Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas.

Authors:  Claire Palles; Jean-Baptiste Cazier; Kimberley M Howarth; Enric Domingo; Angela M Jones; Peter Broderick; Zoe Kemp; Sarah L Spain; Estrella Guarino; Estrella Guarino Almeida; Israel Salguero; Amy Sherborne; Daniel Chubb; Luis G Carvajal-Carmona; Yusanne Ma; Kulvinder Kaur; Sara Dobbins; Ella Barclay; Maggie Gorman; Lynn Martin; Michal B Kovac; Sean Humphray; Anneke Lucassen; Christopher C Holmes; David Bentley; Peter Donnelly; Jenny Taylor; Christos Petridis; Rebecca Roylance; Elinor J Sawyer; David J Kerr; Susan Clark; Jonathan Grimes; Stephen E Kearsey; Huw J W Thomas; Gilean McVean; Richard S Houlston; Ian Tomlinson
Journal:  Nat Genet       Date:  2012-12-23       Impact factor: 38.330
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.